Luma Group founder: ‘We cannot lose the race’ in drug development to China

This becomes a national security issue for the United States,” said Luma Group founder Josh Fink at Semafor World Economy.

DRAGEN v4.5 supports Illumina's new TruPath Genome and 5-base assays, drives insights across germline, oncology, and multiomic workflows

Illumina Inc. (NASDAQ: ILMN) today announced the launch of DRAGEN™ version 4.5 software (v4.5), one of the most substantial expansions of the software's capabilities to date. As genomic researchers ...
Science Daily

Common IBS medications linked to higher risk of death in major study

A massive, nearly 20-year study tracking over 650,000 Americans with irritable bowel syndrome is raising new questions about the long-term safety of common treatments. Researchers found that some ...
eLife

Long-range neural pathways for octopus chemotactile processing revealed from periphery-to-brain by centimeter-field microCT

In this study, the authors use microCT to image an intact hatchling octopus and segment major organ systems, including the vascular, respiratory, digestive, and nervous systems. The resulting dataset ...